Research Institute

Found 2,350 articles

• Florida Cancer Specialists & Research Announces Senior Management Promotions

  1/9/2023

  Florida Cancer Specialists & Research Institute, LLC has announced the promotion of three members of its Senior Management Team.

• City of Hope-led trial leads to U.S. Food and Drug Administration's approval of a first of its kind bispecific antibody

  1/5/2023

  A trial led by City of Hope, one of the largest cancer research and treatment organizations in the nation, contributed to the U.S. Food and Drug Administration's approval of mosunetuzumab, the first bispecific antibody to treat people with relapsed or difficult to treat follicular lymphoma, a type of non-Hodgkin lymphoma, after they have received two or more standard therapies.

• Hospital for Special Surgery Research Institute Awarded Two New Grants to Study Potential Causes of Lupus Flares

  1/5/2023

  A research team led by Hospital for Special Surgery Research Institute, in collaboration with Weill Cornell Medicine, has been awarded two grants, one from the Department of Defense and one from the National Institutes of Health, to conduct groundbreaking research regarding lupus flares.1 Sun exposure can trigger skin lesions and worsening of kidneys or other internal organs affected by lupus, but how inflammation at the skin leads to internal organ effects is unknown.

• Florida Cancer Specialists & Research Institute Appoints New Members to Executive Board

  1/4/2023

  Florida Cancer Specialists & Research Institute, LLC is pleased to welcome newly appointed members, Pareshkumar Patel, MD and Andres Soriano, MD, to its Executive Board, effective January 1, 2023.

• Florida Cancer Specialists & Research Institute Welcomes Indian River Medical Oncologist William T. McGarry, MD

  1/3/2023

  Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Board-certified hematologist and medical oncologist William T. McGarry, MD has joined the statewide practice.

• 

  How a US Recession Could Affect Biopharma

  12/22/2022

  U.S. recession will inevitably make many biopharma companies change course. However, it could cause some biotechs to change for the better. 

• Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

  12/21/2022

  Berkeley Lights and IsoPlexis announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.

• Recce Pharmaceuticals Establishes Anti-Infective Research Unit at Murdoch Children’s Research Institute

  12/19/2022

  Recce Pharmaceuticals Ltd announced the commencement of an Anti-Infective Research Unit through the execution of a research collaboration agreement with Murdoch Children’s Research Institute.

• Texas Biomed at forefront of Sudan ebolavirus biomedical R&D

  12/19/2022

  A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the outbreak there.

• Albert Einstein College of Medicine and Montefiore Health System Receive $5.2 Million NIH Grant to Study Heart Failure in Hispanic Populations

  12/15/2022

  Cardiology researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $5.2 million grant from the National Institutes of Health to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease.

• Florida Cancer Specialists & Research Institute Contributing to Rapid Advancements in Breast Cancer Treatment

  12/13/2022

  Florida Cancer Specialists & Research Institute, LLC hematologists and medical oncologists were contributors to several presentations at the San Antonio Breast Cancer Symposium® this past week, sharing the findings of state-of-the-art breast cancer research conducted at FCS.

• Florida Cancer Specialists & Research Institute Research Breakthroughs Presented at Global Hematology Gathering

  12/13/2022

  Research conducted at Florida Cancer Specialists & Research Institute, LLC that is contributing to global advancements in the diagnosis and treatment of blood diseases was presented at the American Society of Hematology 64th Annual Meeting and Exposition in New Orleans, Louisiana on Dec.

• Texas Biomedical Research Institute in San Antonio Added to National Readiness and Preparedness Network

  12/13/2022

  The federal agency that protects against pandemics and bioterrorism has elevated Texas Biomedical Research Institute into the top ranks of its national readiness and preparedness network.

• City of Hope Study Finds That Neuroendocrine Cancer Patients and Doctors Agree on Treatment Goals Only Half of the Time

  12/12/2022

  A new study by researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, reveals that people with neuroendocrine cancer overwhelmingly prioritize quality of life over living longer.

• $11M NIH Grant Will Support Evaluation of Alzheimer's Screening Tool in Primary Care Settings

  12/8/2022

  Investigators at Albert Einstein College of Medicine, Montefiore Health System, Regenstrief Institute, and Indiana University School of Medicine have received an $11 million grant from the National Institutes of Health to evaluate an Einstein-developed test for assessing cognitive impairment and dementia.

• City of Hope shares in $8 million Prostate Cancer Foundation award to develop CAR T cell therapy for advanced prostate cancer

  12/7/2022

  City of Hope announced it has received, along with other leading cancer centers, an $8 million Therapy ACceleration To Intercept CAncer Lethality award from the Prostate Cancer Foundation to develop clinic-ready chimeric antigen receptor T cell therapies for advanced prostate cancer that can overcome the therapy's current limitations.

• CALYM and Embleema Announce Partnership to Deploy Next-Generation Clinical Research Solutions for Life Sciences

  12/7/2022

  CALYM Carnot Institute and Embleema announced a strategic partnership to develop next-generation clinical research solutions aimed at accelerating clinical innovation.

• Novo Nordisk & ATLATL announce winners in their joint program EntreStar

  12/5/2022

  Novo Nordisk Research Centre China and ATLATL jointly announce the winners of EntreStar program.

• The Gustave Roussy Institute Integrates Synapse Platform to Ensure Complex Prescription Safety

  12/1/2022

  France's Gustave Roussy Institute, Europe's leading cancer center and ranked third in the world according to Newsweek Magazine, has chosen to partner with Synapse Medicine, a leader in clinical pharmacy and medication reconciliation.

• Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies

  11/22/2022

  Florida Cancer Specialists & Research Institute, LLC takes exception to a recent study published in the New England Journal of Medicine suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought.